Related Experiment Video
Updated: Jun 22, 2026

In Vivo Quantitative Assessment of Myocardial Structure, Function, Perfusion and Viability Using Cardiac Micro-computed Tomography
Published on: February 16, 2016
Clinical value, cost-effectiveness, and safety of myocardial perfusion scintigraphy: a position statement
Claudio Marcassa1, Jeroen J Bax, Frank Bengel
1Cardiology Department, S. Maugeri Foundation, IRCCS, Scientific Institute of Veruno, V. Revislate 13, 28010 Veruno, NO, Italy. claudio.marcassa@fsm.it
Insights
Myocardial perfusion scintigraphy (MPS) aids in early detection of coronary artery disease (CAD). This cost-effective tool helps assess cardiac risk and guides treatment decisions for better patient outcomes.
Area of Science:
- Cardiology
- Medical Imaging
Background:
- Coronary artery disease (CAD) remains a leading global cause of death.
- While mortality rates have declined, CAD poses a significant threat, especially in developing nations.
- Early detection and risk stratification are crucial for managing CAD.
Purpose of the Study:
- To highlight the role of Myocardial Perfusion Scintigraphy (MPS) in diagnosing obstructive CAD.
- To emphasize MPS's cost-effectiveness and contribution to patient risk stratification.
- To underscore the importance of MPS in clinical decision-making for CAD management.
Main Methods:
- Myocardial perfusion scintigraphy (MPS) is utilized for diagnostic purposes.
- Evidence-based applications of MPS are reviewed.
- The integration of MPS into clinical practice guidelines is examined.
Main Results:
- MPS is a cost-effective method for early obstructive CAD detection in symptomatic individuals.
- MPS significantly aids in stratifying patients based on cardiac death or myocardial infarction risk.
- MPS provides valuable data for guiding medical treatment and interventions.
Conclusions:
- MPS is an integral tool in current clinical practice for CAD.
- Strong evidence supports the use of MPS in managing patients with suspected or known CAD.
- MPS assists in informed clinical decisions, improving patient care pathways.
Abstract:
Mortality rates due to coronary artery disease (CAD) have declined in recent years as result of improved prevention, diagnosis, and management. Nonetheless, CAD remains the leading cause of death worldwide with most casualties expected to occur in developing nations. Myocardial perfusion scintigraphy (MPS) provides a highly cost-effective tool for the early detection of obstructive CAD in symptomatic individuals and contributes substantially to stratification of patients according to their risk of cardiac death or nonfatal myocardial infarction. MPS also provides valuable information that assists clinical decision-making with regard to medical treatment and intervention. A large body of evidence supports the current applications of MPS, which has become integral to several guidelines for clinical practice.
Related Concept Videos
Radiological Investigation III: Pulmonary Angiogram and PET Scan
Pulmonary Angiogram
A Pulmonary Angiogram is an invasive procedure involving injecting a contrast medium through a catheter threaded into the pulmonary artery or the right side of the heart to visualize the pulmonary vasculature. Computed Tomography (CT) scans have mainly replaced this...
Imaging Studies II: Positron Emission Tomography and Scintigraphy
Fundamental Principles of PET
Imaging Studies for Cardiovascular System IV: CMRI
Imaging Studies for Cardiovascular System V: CT
Imaging Studies for Cardiovascular System VI: Calcium -Scoring CT
Acute Coronary Syndrome III: Diagnostic Studies

